Ghent University Academic Bibliography

Advanced

Safety and efficacy of abexinostat, a pan-histone deacetylase inhibitor, in non-Hodgkin lymphoma and chronic lymphocytic leukemia : results of a phase II study

Vincent Ribrag, Won Seog Kim, Reda Bouabdallah, Soon Thye Lim, Bertrand Coiffier, Arpad Illes, Bernard Lemieux, Martin JS Dyer, Fritz Offner UGent, Zakia Felloussi, et al. (2017) HAEMATOLOGICA. 102(5). p.903-909
Please use this url to cite or link to this publication:
author
year
type
journalArticle (original)
publication status
published
subject
journal title
HAEMATOLOGICA
Haematologica
volume
102
issue
5
pages
903 - 909
ISSN
0390-6078
DOI
10.3324/haematol.2016.154377
language
English
UGent publication?
yes
classification
A1
copyright statement
I have retained and own the full copyright for this publication
id
8513070
handle
http://hdl.handle.net/1854/LU-8513070
date created
2017-03-07 15:06:33
date last changed
2017-06-02 14:01:37
@article{8513070,
  author       = {Ribrag, Vincent and Kim, Won Seog and Bouabdallah, Reda and Lim, Soon Thye and Coiffier, Bertrand and Illes, Arpad and Lemieux, Bernard and Dyer, Martin JS and Offner, Fritz and Felloussi, Zakia and Kloos, Ioana and Luan, Ying and Vezan, Remus and Graef, Thorsten and Morschhauser, Franck},
  issn         = {0390-6078},
  journal      = {HAEMATOLOGICA},
  language     = {eng},
  number       = {5},
  pages        = {903--909},
  title        = {Safety and efficacy of abexinostat, a pan-histone deacetylase inhibitor, in non-Hodgkin lymphoma and chronic lymphocytic leukemia : results of a phase II study},
  url          = {http://dx.doi.org/10.3324/haematol.2016.154377},
  volume       = {102},
  year         = {2017},
}

Chicago
Ribrag, Vincent, Won Seog Kim, Reda Bouabdallah, Soon Thye Lim, Bertrand Coiffier, Arpad Illes, Bernard Lemieux, et al. 2017. “Safety and Efficacy of Abexinostat, a Pan-histone Deacetylase Inhibitor, in non-Hodgkin Lymphoma and Chronic Lymphocytic Leukemia : Results of a Phase II Study.” Haematologica 102 (5): 903–909.
APA
Ribrag, V., Kim, W. S., Bouabdallah, R., Lim, S. T., Coiffier, B., Illes, A., Lemieux, B., et al. (2017). Safety and efficacy of abexinostat, a pan-histone deacetylase inhibitor, in non-Hodgkin lymphoma and chronic lymphocytic leukemia : results of a phase II study. HAEMATOLOGICA, 102(5), 903–909.
Vancouver
1.
Ribrag V, Kim WS, Bouabdallah R, Lim ST, Coiffier B, Illes A, et al. Safety and efficacy of abexinostat, a pan-histone deacetylase inhibitor, in non-Hodgkin lymphoma and chronic lymphocytic leukemia : results of a phase II study. HAEMATOLOGICA. 2017;102(5):903–9.
MLA
Ribrag, Vincent, Won Seog Kim, Reda Bouabdallah, et al. “Safety and Efficacy of Abexinostat, a Pan-histone Deacetylase Inhibitor, in non-Hodgkin Lymphoma and Chronic Lymphocytic Leukemia : Results of a Phase II Study.” HAEMATOLOGICA 102.5 (2017): 903–909. Print.